Heart infection in drug users vs. non-users
Part of Heart & circulation clinical trials.
This study looks at how infective endocarditis (a serious heart infection) differs between people who use intravenous drugs and those who do not. It aims to understand patterns, symptoms, and outcomes to help improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with a definite or possible infection inside your heart (infective endocarditis).
- Your diagnosis of infective endocarditis has not been ruled out by further testing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an observational study that follows people with confirmed infective endocarditis (a serious infection of the heart lining or heart valves). It may help doctors better understand the illness and improve care.
This study tests a new way to find the cause of infective endocarditis, a serious heart infection. It may help doctors choose the right treatment faster.
This study looks at blood and other lab test results (“biomarkers”) to better predict what may happen to people with infective endocarditis, a serious infection of the heart lining or heart valves. Your information may help doctors estimate risk and choose care more safely and effectively.
This study gathers information from patients with a heart infection called endocarditis to help doctors better understand and treat the condition. Anyone aged 16 or older with confirmed or suspected endocarditis who is being treated at Barts Heart Centre may be able to join.
This study looks at how a heart rehabilitation program affects quality of life and personal experiences in people who have been treated for infective endocarditis (a serious heart infection). It aims to find out if this type of rehab helps patients feel better and recover more fully.
This trial measures how your body handles certain intravenous antibiotics used for endocarditis, an infection of the heart valves. It may help doctors understand the best antibiotic dosing for people with valve infections.
Hear when a new Infective Endocarditis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.